The European cell sheet-based gene treatment market is experiencing significant growth. This field is driven by an increasing need for innovative therapeutic solutions to address a wide range of genetic disorders. Effective clinical trials and regulatory approvals are fueling market progress. A key factor contributing to this phenomenon is the abil